摘要
心房颤动(房颤)是人群中最常见的心律失常之一,可引起一系列临床症状,并导致严重并发症,如心力衰竭和卒中,使患者全因死亡风险显著增高。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2013年第12期1068-1070,共3页
Chinese Journal of Internal Medicine
参考文献25
-
1Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001,285 : 2370-2375.
-
2Swedberg K, Olsson LG, Charlesworth A, et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J, 2005,26 : 1303-1308.
-
3Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med, 1994,154:1449-1457.
-
4Stewart S, Hart CL, Hole D J, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med, 2002,113 : 359-364.
-
5Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation,2009,119:480-486.
-
6戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
-
7Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 1998,98:946-952.
-
8Lavy S, Stern S, Melamed E, et al. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke, 1980,11:35- 38.
-
9Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta- analysis. Ann Intern Med, 1999,131:492-501.
-
10Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke, 2000,31 : 817-821.
共引文献1638
-
1俞娅娅,李小荣,余金波,杨兵.心房颤动综合管理ABC方案[J].中国心脏起搏与心电生理杂志,2020,0(1):7-10. 被引量:10
-
2周睿,王禹川.心房颤动患者的规范化治疗[J].慢性病学杂志,2022(10):1468-1471.
-
3丁小亮.老年非瓣膜性心房颤动经利伐沙班治疗的安全性评价[J].世界最新医学信息文摘,2019,0(81):120-120. 被引量:1
-
4贺毅,李志超,王伟文(综述),廖晓阳(审校).无创筛查阵发性心房颤动研究进展[J].武警医学,2020,0(1):77-81. 被引量:3
-
5夏熠,李道博,王运松,高睿媛,董颖雪,尹晓盟,高连君,夏云龙.中性粒细胞与淋巴细胞比值对非瓣膜病心房颤动患者射频消融围术期抗凝出血风险的预测价值[J].临床心血管病杂志,2020,36(1):55-59. 被引量:9
-
6蔡小娟,陈艳.我国脑卒中流行及防控现状[J].广东医学,2019,40(S01):212-215. 被引量:33
-
7顾智淳,张在丽,刘晓琰.1例胺碘酮致华法林国际标准化比值升高的病例分析[J].医药导报,2015,34(S01):172-173. 被引量:1
-
8冯琳琳,纪文岩.从肝肾论治老年性房颤举隅[J].世界最新医学信息文摘,2020(11):226-227.
-
9卢建平.96例老年心房颤动患者的临床诊疗体会[J].临床研究,2014,22(11):29-29.
-
10桑叶.44例心房纤颤合并长间期临床意义分析[J].医学信息(医学与计算机应用),2014,0(30):254-254.
同被引文献66
-
1赵洁,李超鹏,张之慧.心房颤动患者华法林抗凝治疗依从性调查分析[J].农垦医学,2014,36(1):68-71. 被引量:3
-
2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
-
3Go A S,Hylek E M,Phillips K A,et al.Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the An Ticoagulation and Risk Factors in Atrial Fibrillation(ATRIA)Study[J].JAMA,2001,285(18):2370-2375.
-
4Swedberg K,Olsson L G,Charlesworth A,et al.Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers:results from COMET[J].Eur Heart J,2005,26(13):1303-1308.
-
5Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154(13):1449-1457.
-
6Stewart S,Hart C L,Hole D J,et al.A population-based study of the long-term risks associated with atrial fibrillation:20-year follow-up of the Renfrew/Paisley study[J].Am J Med,2002,113(5):359-364.
-
7Benjamin E J,Wolf P A,D'Agostino R B,et al.Impact of atrial fibrillation on the risk of death:the Framingham Heart Study[J].Circulation,1998,98(10):946-952.
-
8Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial [J ]. Lancet, 2007,370 (9586): 493-503.
-
9Friherg L, Ro senqvist M, Lip GY, et aL Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study [J]. Circulation, 2012, 125 (19): 2298-2307.
-
10Fiberg L,Hammar N,Rosenqvist M.Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation [J ].Eur Heart J,2010,31 (8):967-975.
引证文献9
-
1曹文斋,张婷,钟德超,石兆云,余江恒.心房颤动社区管理依从性分析[J].中国医学创新,2015,12(13):106-108. 被引量:5
-
2杨静,杨玉琴.金昌市人民医院非瓣膜病心房颤动患者抗凝治疗现状分析[J].甘肃医药,2015,34(9):672-674.
-
3周琼,何水带,韩艳.酒石酸美托洛尔联合稳心颗粒对冠心病心律失常的治疗效果观察[J].中国当代医药,2016,23(27):113-115. 被引量:3
-
4金文杰.阿托伐他汀联合缬沙坦对永久性房颤患者心脏重构及炎症因子水平的影响[J].现代医学,2016,44(10):1399-1402. 被引量:4
-
5苗靖文,郭涛.探讨非瓣膜性心房颤动的抗凝治疗[J].中国医药科学,2016,6(19):55-57. 被引量:2
-
6张凤艳,冯天元,徐建,孙红疆,黄成林,倪国贞,马赟聪.社区管理对农村心房颤动患者抗凝效果的影响[J].中国慢性病预防与控制,2018,26(6):467-470. 被引量:3
-
7倪秋明,林苗,季晓君,杨德业.房颤中心建设对房颤患者治疗效果的影响[J].现代实用医学,2020,32(10):1196-1198. 被引量:1
-
8白燕玲,魏召义,杨静.非瓣膜病心房颤动住院患者抗凝治疗现状及影响因素探讨[J].实用临床护理学电子杂志,2017,2(2). 被引量:1
-
9云电.老年心房颤动患者死亡的相关因素[J].中国老年学杂志,2015,35(6):1546-1547. 被引量:9
二级引证文献28
-
1吴彬,程春莲.坎地沙坦酯联合阿托伐他汀治疗阵发性心房颤动的效果及对心功能和血浆N-末端B型利钠肽原浓度的影响[J].心血管病防治知识(学术版),2020(32):44-46. 被引量:1
-
2王桂萍,方伟钧,潘锋君,王琳青.胺碘酮联合缬沙坦治疗老年阵发性心房颤动的临床观察[J].中国药房,2015,26(36):5102-5104. 被引量:12
-
3刘春玲,刘连女,刘亚玲,刘杰,贾子雷,夏铁路,郭亚东.急性左心衰病发致死性心律失常死亡的危险因素[J].黑龙江医药,2016,29(1):115-116. 被引量:1
-
4李波.华法林在心房颤动抗凝治疗中的应用探讨[J].中外医学研究,2016,14(17):158-160.
-
5金勇.老年心房颤动患者合并脑血管病危险因素分析[J].中国实用医药,2017,12(13):35-36. 被引量:2
-
6彭明,张树龙.心房颤动转归HATCH评分系统的综合评价[J].实用心电学杂志,2016,25(5):369-372.
-
7张金莲,林超,刘焕兵.老年人房颤社区管理存在的问题及对策[J].实用老年医学,2018,32(7):603-606. 被引量:3
-
8乔燕.房颤患者的脑血管功能变化特征及脑卒中风险分析[J].中国继续医学教育,2018,10(23):56-57. 被引量:2
-
9张琳,陈艳炯,吴柏云,刘军辉,洪舟,李娜,封婧,陶丹.左心房内径、超敏C反应蛋白、脑尿钠肽与老年非瓣膜性心房颤动的关系[J].中国医药导报,2018,15(35):66-69. 被引量:5
-
10夏琨,孙东明,张勇,蔡珊珊.美托洛尔对急性心律失常患儿的疗效及对血清心肌酶和炎症因子的影响[J].东南大学学报(医学版),2018,37(6):1037-1040. 被引量:6
-
1戴丽莹,干倩,周清芬,任妍,虞莹珺,张凤如.胆固醇水平对慢性心力衰竭患者预后的影响[J].国际心血管病杂志,2012,39(1):53-55. 被引量:2
-
2程红颖,张瑞凤.胆固醇水平对慢性心力衰竭患者预后独立预测的价值[J].河北联合大学学报(医学版),2014,16(2):243-244.
-
3田明,谢东明,董淑惠,章隽,王耀辉.合并2型糖尿病的老年NSTEMI患者应用替罗非班的疗效和安全性研究[J].中国当代医药,2013,20(1):66-67. 被引量:1
-
4程中伟,朱孔博,方理刚,张抒扬,严晓伟,朱文玲,方全.贫血增加慢性心力衰竭患者死亡率[J].中国心血管杂志,2012,17(3):193-196. 被引量:2